4502:TYO
Takeda Pharmaceutical Co Ltd
Â¥6,926.00
arrow_upward
+1.48%(+101.00) 1D
Nov 13, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4502...
Open
Â¥6,751
High
Â¥6,926
Low
Â¥6,740
Mkt. cap
11.10T
Avg. vol.
4.80M
Volume
4.42M
Dividend
2.92%
Quarterly dividend
Â¥50
Ex-dividend date
Mar 30, 2027
P/E ratio
330.76
52-wk high
Â¥6,989
52-wk low
Â¥4,324
EPS
Â¥21
Shares outstanding
784.48M
No. of employees
47K
Open
Â¥6,751
High
Â¥6,926
Low
Â¥6,740
Mkt. cap
11.10T
Avg. vol.
4.80M
Volume
4.42M
Dividend
2.92%
Quarterly dividend
Â¥50
Ex-dividend date
Mar 30, 2027
P/E ratio
330.76
52-wk high
Â¥6,989
52-wk low
Â¥4,324
EPS
Â¥21
Shares outstanding
784.48M
No. of employees
47K
News stories
From web sources and news partners
Investing.com
·
1 day ago
Takeda launches narcolepsy drug Orzeyful in U.S. market
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitetakeda.com